Beneficial effects of pentoxifylline pretreatment in non-heart-beating donors in rats

Transplantation

Volumn 69, Issue 1, 2000, Pages 93-98

  Astarcioǧlu, Hüseyin ^a,b   Karademir, Sedat ^a   Ünek, Tarkan ^a   Özer, Erdener ^a   Menekay, Serra ^a   Çoker, Ahmet ^a   Astarcioǧlu, Ibrahim ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b Mehmetcik Bulvari   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

PENTOXIFYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DONOR; GRAFT PRESERVATION; LIVER PRESERVATION; LIVER TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECIPIENT; SURVIVAL RATE;

EID: 0034650532     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200001150-00017     Document Type: Article

References (30)

1. Van Thiel DH. Liver transplantation: a history of the past and present with a vision of the future. In: Maddrey WC, Sorrell MF, eds. Transplantation of the liver. East Norwalk, CT: Appleton & Lange, 1995: 1.
2. Alexander JW, Zola JC. Expanding the donor pool: use of marginal donor for solid organ transplantation. Clin Transplant 1996; 10: 1.
3. Kalayoglu M, Hoffman RM, D'Allessandro AM, et al. Clinical results in liver transplantation using UW solution for extended preservation. Transplant Proc 1989; 21: 3487.
4. Nicholson ML, Dunlop P, Doughnan TM, et al. Work-load generated by the establishment of non-heart beating kidney transplant programme. Transplant Int 1996; 9: 603.
5. Rapaport FT. Progress in organ procurement: the non heart-beating cadaver donor and other issues in transplantation. Transplant Proc 1991; 23: 2699.
6. Hoshino T, Koyama I, Nagashima N, et al. Liver transplantation from non heart-beating donors by core cooling technique. Transplant Proc 1989; 21: 1206.
7. Yanaga K, Kakizoe S, Ikeda T, et al. Procurement of liver allografts from non-heart beating donors. Transplant Proc 1990; 22: 275.
8. D'Allessandro AM, Hoffmann RM, Knechtle SJ, et al. Controlled non heart-beating donors: a potential source of extrarenal organs. Transplant Proc 1995; 27: 707.
9. Casaville A, Ramirez C, Shapiro R, et al. Liver and kidney transplantation from non heart-beating donors: Pittsburgh experience. Transplant Proc 1995; 27: 710.
10. Xu HS, Stevenson WC, Pruett TL, et al. Donor lazaroid pretreatment improves viability of livers harvested from non heart-beating rats. Am J Surg 1996; 171: 113.
11. Ware F, Goto S, Kamada N, et al. Effect of a prolonged anhepatic phase and PGE1 on intraoperative hemodynamic changes and graft survival in rat liver transplantation. Transplant Proc 1994; 26: 2265.
12. Wang P, Ba ZF, Zhou M, et al. Pentoxifylline restores cardiac output and tissue perfusion after trauma-hemorrhage and decreases susceptibility to sepsis. Surgery 1993; 114: 352.
13. Kozaki K, Egawa H, Bermudas L, et al. Effect of pentoxifylline pretreatment on Kupffer cells in rat liver transplantation. Hepatology 1995; 121: 1079.
14. Bachmann S, Caldwell-Kenkel JC, Currin RT, et al. Protection by pentoxifylline against graft failure from storage injury after orthotopic rat liver transplantation with arterialization. Transplant Int 1992; 5 (suppl 1): S345.
15. Bachmann S, Caldwell-Kenkel JC, Currin RT, et al. Ultrastructural correlates of liver graft failure from storage injury: studies of graft protection by Caroline Rinse solution and pentoxifylline. Transplant Proc 1993; 25: 1620.
16. Peng XX, Currin RT, Thurman RG, et al. Protection by pentoxifylline against normothermic liver ischemia-reperfusion in rats. Transplantation 1995; 59: 1537.
17. Fabia R, Travis DL, Levy MF, et al. Effect of pentoxifylline on hepatic ischemia and reperfusion injury. Surgery 1997; 121: 520.
18. Kozaki K, Egawa H, Bermudes L, et al. Pentoxifylline inhibits production of Superoxide anion and tumor necrosis factor by Kupffer cells in rat liver preservation. Transplant Proc 1993; 25: 3025.
19. Kamada N, Calne RY. A surgical experience with five hundred thirty liver transplants in the rat. Surgery 1983; 93: 64.
20. Azoulay D, Astarcioglu I, Lemoine A, et al. The effects of donor and recipient endotoxemia on TNF-α production and mortality in the rat model of syngenic orthotopic liver transplantation. Transplantation 1995; 59: 825.
21. Marzi I, Walcher F, Bühren V. Improvement of liver preservation by the calcium channel blocker nisoldipine: an experimental study applying intravital microscopy to transplanted rat livers. Transplant Int 1992; 5 (suppl 1): S395.
22. Savier E, Shedlofsky SI, Swim AT, et al. The calcium channel blocker nisoldipine minimizes the release of tumor necrosis factor and interleukin-6 following rat liver transplantation. Transplant Int 1992; 5 (suppl 1): S398.
23. Sikujara O, Monden M, Toyoshima K, et al. Cytoprotective effect of prostaglandin I2 on ischemia-induced hepatic cell injury. Transplantation 1983; 36: 238.,
24. Cicalase L, Lee K, Schraut W, et al. Pyruvate prevents ischemia-reperfusion injury of rat small intestine. Am J Surg 1996; 171: 97.
25. Lemasters JJ, Bunzendahl K, Thurman RG. Reperfusion injury to donor livers stored for transplantation. Liver Transplant Surg 1995; 1: 124.
26. Furukawa H, Todo S, Imventarza O, et al. Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solution. Transplantation 1991; 51: 1000.
27. Currin RT, Reinstein LJ, Lichtman SN, et al. Inhibition of tumor necrosis factor release from cultured rat Kupffer cells by agents that reduce graft failure from storage injury. Transplant Proc 1993; 25: 1631.
28. Lemasters JJ, Thurman RG. The many facets of reperfusion injury. Gastroenterology 1995; 108: 1317.
29. Zabel P, Wolter DT, Schönharting MM, et al. Oxypentoxifylline in endotoxaemia. Lancet 1989; 23: 1474.
30. Wang P, Ba ZF, Morrison MH, et al. Mechanism of the beneficial effects of pentoxifylline on hepatocellular function after trauma hemorrhage and resuscitation. Surgery 1992; 112: 451.